Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Forum Dermatologicum
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2023

Vol 7, No 1 (2021)
Case report
Published online: 2021-03-17
Add to basket: 49.00 PLN
Get Citation

Primary cutaneous T cel lymphoma in a pregnant woman — a therapeutic challenge

Anna Ciesielka1, Paweł Plata2, Katarzyna Kosior3, Adam Reich4
DOI: 10.5603/FD.a2021.0005
·
Forum Dermatologicum 2021;7(1):17-22.
Affiliations
  1. Studenckie Koło Naukowe Dermatologii Eksperymentalnej przy Zakładzie i Klinice Dermatologii, Kolegium Nauk Medycznych, Uniwersytet Rzeszowski
  2. Klinika Onkologii Klinicznej, Kliniczny Szpital Wojewódzki nr 1 im. Fryderyka Chopina w Rzeszowie
  3. Kliniczny Zakład Patomorfologii, Kliniczny Szpital Wojewódzki nr 1 im. Fryderyka Chopina w Rzeszowie
  4. Zakład i Klinika Dermatologii, Instytut Nauk Medycznych, Kolegium Nauk Medycznych, Uniwersytet Rzeszowski

paid access

Vol 7, No 1 (2021)
CASE STUDY
Published online: 2021-03-17

Abstract

Primary cutaneous lymphomas represent a heterogeneous group of lymphoproliferative disorders. Here, we have demonstrated a case of the primary cutaneous T-cell lymphoma (CTCL) in a 28-year-old pregnant woman. The patient is demonstrated because of aggressive clinical course, and therapeutic difficulties of CTCL during pregnancy. CTCL are a group of rarely occurring neoplasms and the presence of CTCL during pregnancy can be an additional diagnostic and therapeutic challenge that needs multidisciplinary healthcare approach.

Abstract

Primary cutaneous lymphomas represent a heterogeneous group of lymphoproliferative disorders. Here, we have demonstrated a case of the primary cutaneous T-cell lymphoma (CTCL) in a 28-year-old pregnant woman. The patient is demonstrated because of aggressive clinical course, and therapeutic difficulties of CTCL during pregnancy. CTCL are a group of rarely occurring neoplasms and the presence of CTCL during pregnancy can be an additional diagnostic and therapeutic challenge that needs multidisciplinary healthcare approach.

Full Text:

Add to basket: 49.00 PLN
Get Citation

Keywords

cutaneous lymphomas; pregnancy; treatment

About this article
Title

Primary cutaneous T cel lymphoma in a pregnant woman — a therapeutic challenge

Journal

Forum Dermatologicum

Issue

Vol 7, No 1 (2021)

Article type

Case report

Pages

17-22

Published online

2021-03-17

Page views

376

Article views/downloads

35

DOI

10.5603/FD.a2021.0005

Bibliographic record

Forum Dermatologicum 2021;7(1):17-22.

Keywords

cutaneous lymphomas
pregnancy
treatment

Authors

Anna Ciesielka
Paweł Plata
Katarzyna Kosior
Adam Reich

References (32)
  1. Sokołowska-Wojdyło M. Pierwotne chłoniaki skóry. In: Krzakowski M, Warzocha K. ed. Zalecenia postępowania diagnostyczno-terapeutycznego w nowotworach złośliwych. Tom II. Via Medica, Gdańsk 2013: 948–968.
  2. Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016; 127(20): 2375–2390.
    CrossRefPubMed
  3. Jaffe E, Swerdlow SHCE, Campo E, Pileri, S, Thiele J, Harris N, Stein HT, Wardiman JW. WHO classification of tumours of the haematopoietic and lymphoid tissues. World Health Organisation, Genewa 2008.
  4. Öztürk M, Dede M, Çoksüer H, et al. Mycosis fungoides and pregnancy: a case report. Kocatepe Med J . 2012; 13: 43–46.
  5. Fatemi Naeini F, Abtahi-Naeini B, Najafian J, et al. Correlation between mycosis fungoides and pregnancy. Saudi Med J. 2016; 37(9): 968–972.
    CrossRefPubMed
  6. Naeini FF, Najafian J, Nilforoushzadeh M. CD30+ Large Cell Transformation of Mycosis Fungoides During Pregnancy. Indian J Dermatol. 2013; 58(2): 160.
    CrossRefPubMed
  7. Vergier B, de Mu, Beylot-Barry M, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas. Blood. 2000; 95: 2212–2218.
  8. Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides/Sezary syndrome: clinical characteristics and prognosis. Blood. 1998; 92(4): 1150–1159.
    PubMed
  9. Amitay-Layish I, David M, Kafri B, et al. Early-stage mycosis fungoides, parapsoriasis en plaque, and pregnancy. Int J Dermatol. 2007; 46(2): 160–165.
    CrossRefPubMed
  10. Castelo-Branco C, Torné A, Cararach V, et al. Mycosis fungoides and pregnancy. Oncol Rep. 2001; 8(1): 197–199.
    CrossRefPubMed
  11. Echols KT, Gilles JM, Diro M. Mycosis fungoides in pregnancy: remission after treatment with f -interferon in a case refractory to conventional therapy: a case report. J Matern Fetal Med. 2001; 10(1): 68–70.
    CrossRef
  12. Wilcox RA. Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. Am J Hematol. 2017; 92(10): 1085–1102.
    CrossRefPubMed
  13. Agar NS, Wedgeworth E, Crichton S, et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol. 2010; 28(31): 4730–4739.
    CrossRefPubMed
  14. Kim EJ, Hess S, Richardson SK, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005; 115(4): 798–812.
    CrossRefPubMed
  15. Krejsgaard T, Lindahl LM, Mongan NP, et al. Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeover. Semin Immunopathol. 2017; 39(3): 269–282.
    CrossRefPubMed
  16. Litvinov IV, Cordeiro B, Fredholm S, et al. Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell lines. Cell Cycle. 2014; 13(18): 2975–2982.
    CrossRefPubMed
  17. Tancrède-Bohin E, Ionescu MA, de La Salmonière P, et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol. 2004; 140(9): 1057–1061.
    CrossRefPubMed
  18. La Rocca C, Carbone F, Longobardi S, et al. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014; 162(1 Pt A): 41–48.
    CrossRefPubMed
  19. Kwiatek M, Kwaśniewska A. Rola komórek T regulatorowych w ciąży. Post Biol Kom. 2011; 38: 395–406.
  20. Yip L, McCluskey J, Sinclair R. Immunological aspects of pregnancy. Clin Dermatol. 2006; 24(2): 84–87.
    CrossRefPubMed
  21. Rubach M, Litwiniuk M, et al. Mądry R Cancer in pregnant women. Oncol Clin Pract. 2018; 4: 68–85.
  22. Sagan D, Semczuk A, Lampka E. Combination chemotherapy for Hodgkin's lymphoma during pregnancy: favorable outcome for mother and child. J Obstet Gynaecol Res. 2010; 36(4): 882–886.
    CrossRefPubMed
  23. Bachanova V, Connors JM, Bachanova V. Hodgkin lymphoma in pregnancy. Curr Hematol Malig Rep. 2013; 8(3): 211–217.
    CrossRefPubMed
  24. Pereg D, Koren G, Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica. 2007; 92(9): 1230–1237.
    CrossRefPubMed
  25. Pereg D, Koren G, Lishner M. Cancer in pregnancy: gaps, challenges and solutions. Cancer Treat Rev. 2008; 34(4): 302–312.
    CrossRefPubMed
  26. El-Hemaidi I, Robinson SE. Management of haematological malignancy in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2012; 26(1): 149–160.
    CrossRefPubMed
  27. Avivi I, Farbstein D, Brenner B, et al. Non-Hodgkin lymphomas in pregnancy: tackling therapeutic quandaries. Blood Rev. 2014; 28(5): 213–220.
    CrossRefPubMed
  28. Vandenbriele C, Dierickx D, Amant F, et al. The treatment of hematologic malignancies in pregnancy. Facts Views Vis Obgyn. 2010; 2(2): 74–87.
    PubMed
  29. Avilés A, Neri N, Nambo MJ. Hematological malignancies and pregnancy: treat or no treat during first trimester. Int J Cancer. 2012; 131: 2678–2683.
  30. Azim HA, Pavlidis N, Peccatori FA. Treatment of the pregnant mother with cancer: a systematic review on the use of cytotoxic, endocrine, targeted agents and immunotherapy during pregnancy. Part II: Hematological tumors. Cancer Treat Rev. 2010; 36(2): 110–121.
    CrossRefPubMed
  31. Evens A, Lishner M, Avivi I, et al. Hodgkin lymphoma and non-Hodgkin lymphoma. Textbook of Cancer in Pregnancy. 2017: 111–118.
  32. Froesch P, Belisario-Filho V, Zucca E. Hodgkin and non-Hodgkin lymphomas during pregnancy. Recent Results Cancer Res. 2008; 178: 111–121.
    CrossRefPubMed

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone: +48 58 320 94 94, fax: +48 58 320 94 60, e-mail: viamedica@viamedica.pl